Reporting owner · Q3 2026 · CIK 1191905

Kumar Amit: insider trades.

Kumar Amit reported 9 non-derivative transactions on 9 SEC ownership filings in Q3 2026: 9 open-market purchases ($130K) and 0 sales, across 1 company.

Transactions
9
Purchases (P)
9
Sales (S)
0
Companies
1
Name as filed
KUMAR AMIT

Companies

CompanyRelationshipTransactions
Anixa Biosciences Inc (ANIX)Director, Officer · Chief Executive Officer9

Transactions

9 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-24Anixa Biosciences IncP7,000$2.78672,000Form 4
2026-09-10Anixa Biosciences IncP3,000$2.75665,000Form 4
2026-09-10Anixa Biosciences IncP5,000$2.76662,000Form 4
2026-07-31Anixa Biosciences IncP5,000$3.47657,000Form 4
2026-07-27Anixa Biosciences IncP5,000$3.44652,000Form 4
2026-07-27Anixa Biosciences IncP3,188$3.37647,000Form 4
2026-07-24Anixa Biosciences IncP3,000$3.73643,812Form 4
2026-07-20Anixa Biosciences IncP5,000$3.46640,812Form 4
2026-07-10Anixa Biosciences IncP5,000$3.04635,812Form 4

Questions

What stock did Kumar Amit buy or sell?

Kumar Amit reported 9 non-derivative transactions on 9 SEC ownership filings in Q3 2026: 9 open-market purchases ($130K) and 0 sales, across 1 company.

Is Kumar Amit the same person as other filers with this name?

This page covers SEC CIK 1191905 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/kumar-amit-1191905.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.